Abel Teo Jun Hieng

Abel Teo is addressing a familiar piece of care that has changed little for decades: the plaster cast. His company's thermally activated, 4D-printed orthopaedic support is designed to be applied in under five minutes, remain breathable and reduce the weight and mess associated with conventional casting. Public product records describe Class I registration in Singapore, South Korea, Taiwan and Australia.

In 2026, Castomize appeared as the industrial collaborator in a registered pilot protocol examining the device in clinical workflow. That protocol is evidence of a serious evaluation pathway, not evidence that the trial has produced a positive result. Teo's personal agency is direct as technical cofounder and chief executive, translating materials engineering into manufacturing, regulatory documentation and hospital testing.

Class I registration generally reflects a lower-risk device category and should not be mistaken for proof of superior healing or patient outcomes. No completed trial result or treated-patient denominator was publicly available at the assessment date. Teo's inclusion recognizes the disciplined movement of a practical Singaporean device into multi-market registration and prospective evaluation.